Genedrive Share News (GDR)

Genedrive Information

Buy GDR Shares
Add GDR to Watchlist
Add GDR to Alert

Share Price Information for Genedrive (GDR)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 5.00

Bid: 4.75

Ask: 5.25

Change: -0.375 (-6.98%)

Spread: 0.50 (10.526%)

Open: 5.375

High: 5.375

Low: 5.00

Prev. Close: 5.375

Last checked at -

IN BRIEF: Genedrive receives Indian import license for Covid test kit

Fri, 25th Jun 2021 14:39

Genedrive PLC - Manchester, England-based molecular diagnostics firm - Confirms it has received license to import its SARS-CoV-2 kit into India via its partner DIVOC Health. Genedrive received approval from the Indian Council of Medical Research for its Covid testing kit back in April.

Genedrive's 96 SARS-CoV-2 Kit is designed to detect active infection in Covid patients and eliminates the need for cold temperature storage, making it ideal for high temperature countries such as India.

Current stock price: 55.87 pence, up 13% on Friday

Year-to-date change: up 15%

By Will Paige; willpaige@alliancenews.com

More News

2 Dec 2021 10:37

AIM WINNERS & LOSERS: Digitalbox shares surge on earnings outlook

29 Nov 2021 20:22

IN BRIEF: Genedrive shares soar on bid to get Covid test EU approval

29 Nov 2021 15:13

Genedrive submits new Covid-19 test for EU certification

(Sharecast News) - Molecular diagnostics company Genedrive has submitted its new rapid point-of-care molecular Covid-19 test for CE-IVD certification in Europe, it announced on Monday.

16 Nov 2021 14:35

EXECUTIVE CHANGES: Countryside Properties and musicMagpie poach CFOs

9 Nov 2021 22:01

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

9 Nov 2021 15:02

Revenues fall, losses narrow for Genedrive

(Sharecast News) - Near-patient molecular diagnostics company Genedrive reported revenue of £0.7m in its final results on Tuesday, down from £1.1m year-on-year.

2 Nov 2021 16:01

UK earnings, trading statements calendar - next 7 days

29 Sep 2021 18:23

TRADING UPDATES: Fulham Shore mulls dividend; LoopUp swings to loss

29 Sep 2021 13:08

Genedrive gets CE-IVD marking for new system platform

(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Wednesday that the new-generation 'Genedrive System' platform, which was developed to support the commercial launch of the 'Genedrive MT-RNR1' ID kit, had now received CE-IVD marking in anticipation of launch in the UK and the European Union.

23 Sep 2021 16:03

Latest Share Chat

Genedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

IN BRIEF: Genedrive receives Indian import license for Covid test kit

AIM WINNERS & LOSERS: Digitalbox shares surge on earnings outlook

IN BRIEF: Genedrive shares soar on bid to get Covid test EU approval

Genedrive submits new Covid-19 test for EU certification

EXECUTIVE CHANGES: Countryside Properties and musicMagpie poach CFOs

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

Revenues fall, losses narrow for Genedrive

UK earnings, trading statements calendar - next 7 days

TRADING UPDATES: Fulham Shore mulls dividend; LoopUp swings to loss

Genedrive gets CE-IVD marking for new system platform

UK shareholder meetings calendar - next 7 days

TRADING UPDATES: Argo gets GBP18 million loan; Genedrive fundraises

TRADING UPDATES: Jet2 in bumper Airbus order; Strix China factory live

Genedrive to seek CE mark clearance for MT-RNR1 assay

TRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free

Genedrive makes progress with Covid-19 test development

Latest Share Chat

Genedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Genedrive receives Indian import license for Covid test kit

Login to your account

Quickpicks are a member only feature

Login to your account